SCHEMBL21541995

SCHEMBL21541995

COc1ccccc1CNc1nc(NCCCN2CCCC2=O)c2sccc2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYRO3 Q06418 4/20 0.54
SELP P16109 2/20 0.54
MET P08581 1/20 0.54
AXL P30530 1/20 0.54
MERTK Q12866 1/20 0.54
PGK1 P00558 1/20 0.51
PDE4A P27815 1/20 0.51
PDE4B Q07343 1/20 0.51
PDE4C Q08493 1/20 0.51
PDE4D Q08499 1/20 0.51
PDE3B Q13370 1/20 0.51
PDE3A Q14432 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.47
ADORA1 P30542 1/20 0.41
MKNK1 Q9BUB5 2/20 0.41
MKNK2 Q9HBH9 2/20 0.41
NPC1 O15118 1/20 0.40
ATM Q13315 1/20 0.40
ALDH1A1 P00352 3/20 0.40
MAPT P10636 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26744585 0.86 PGK1 (0.49) TYRO3SELPMETAXLMERTK
SCHEMBL20399062 0.83 MKNK1 (0.42) TYRO3SELPMETAXLMERTK
SCHEMBL20399138 0.75 ADORA1 (0.45) PGK1PDE4APDE4BPDE4CPDE4D
SCHEMBL21567225 0.74 PDE4A (0.63) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL30092941 0.74 PDE4A (0.63) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL26741836 0.73 MKNK1 (0.41) TYRO3ADORA1MKNK1MKNK2ATM
SCHEMBL21567267 0.73 ALDH1A1 (0.56) PGK1PDE4APDE4BPDE4CPDE4D
SCHEMBL1291766 0.69 PGK1 (1.00) PGK1L3MBTL1ALDH1A1MAPTKDM4E
SCHEMBL9830341 0.68 PGK1 (0.63) PGK1POLB
SCHEMBL7484195 0.67 ACHE (0.68) L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12545675-B2 Anti-wolbachia pyrido[2,3-d]pyrimidine compounds LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2026-02-10 US disclosed
US-20230348460-A1 ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2023-11-02 US disclosed
US-20230348460-A1 ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2023-11-02 US disclosed
US-20230348460-A1 ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2023-11-02 US disclosed
US-11518760-B2 Anti-Wolbachia pyrido[2,3-d]pyrimidine compounds LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2022-12-06 US disclosed
US-20190345157-A1 COMPOUNDS EISAI R&D MANAGEMENT CO., LTD. (JP) 2019-11-14 US disclosed
US-20190345157-A1 COMPOUNDS EISAI R&D MANAGEMENT CO., LTD. (JP) 2019-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12545675-B2 Anti-wolbachia pyrido[2,3-d]pyrimidine compounds CBR1, CBR3, COX6C TYRO3 999/4885SELP 2166/4885MET 3004/4885
US-20230348460-A1 ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS PWWP2B, WARS1, PNPO TYRO3 1972/4885SELP 3790/4885MET 4872/4885
US-20190345157-A1 COMPOUNDS ABCB11, LTC4S, AQP1 TYRO3 2805/4885SELP 395/4885MET 4288/4885
US-11518760-B2 Anti-Wolbachia pyrido[2,3-d]pyrimidine compounds P2RX5, PNPO, P2RX3 TYRO3 1572/4885SELP 3692/4885MET 4872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.